Liver Disease
Conference Coverage
PI-based DAAs appear safe in decompensated patients
Study shows similar tolerability with PI- and non-PI based therapies, but questions remain for Child-Pugh Score B and C.
Conference Coverage
Treatment for alcohol abuse reduces hepatitis readmission
However, these support systems are not always feasible or easy to introduce.
From the Journals
Creatinine variability linked to liver transplant outcomes
Findings suggest that a more dynamic approach in liver allocation strategies is needed.
Conference Coverage
A surprise and a mystery: NAFLD in lean patients linked to CVD risk
The link between nonalcoholic fatty liver disease and higher risk of CVD may extend beyond people who are overweight or living with obesity.
From the Journals
NAFLD vs. MAFLD: What’s in a name?
NAFLD may not be the most appropriate name because “nonalcoholic” may overemphasize the absence of alcohol, but is “metabolic associated” any...
Feature
DOJ complaint flags HCV drug denials for people with addiction
Alabama Medicaid has an illegal policy of denying HCV treatment to people who have used illegal drugs or alcohol, according to the complaint.
From the Journals
PPIs should be used ‘judiciously’ in patients with cirrhosis
“Experts call for “nuanced” prescribing of proton pump inhibitors to patients with cirrhosis in study that found lower mortality only in those...
Commentary
Alarming global rise in pediatric hepatitis: Expert Q&A
For pediatricians, an awareness of the “outbreak” may allow the clinician to extend the typical workup of a child presenting with an undefined,...
From the Journals
Newly defined liver disorder associated with COVID mortality
From the Journals
To engage injection drug users in HCV care, go to where they are